Autologous T-Cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Cancer Research - United States
doi 10.1158/0008-5472.can-14-0296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Clinical Chimeric Antigen Receptor‐T Cell Therapy: A New and Promising Treatment Modality for Glioblastoma

Clinical and Translational Immunology
AllergyImmunologyNursing
2019English

Autologous Whole-Tumor Antigen Vaccination in Combination With Adoptive T Cell Therapy for Patients With Recurrent Ovarian Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

High-Dose BCNU With Autologous Bone Marrow Rescue for Recurrent Glioblastoma Multiforme

Journal of Neurosurgery
SurgeryNeurology
1981English

Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus Pp65-Specific Cytotoxic T Cells

Clinical Cancer Research
Cancer ResearchOncology
2014English

Dexamethasone Exerts Profound Immunologic Interference on Treatment Efficacy for Recurrent Glioblastoma

British Journal of Cancer
Cancer ResearchOncology
2015English

A Role for Cytomegalovirus-Specific CD4+CX3CR1+ T Cells and Cytomegalovirus-Induced T-Cell Immunopathology in HIV-associated Atherosclerosis

AIDS
Infectious DiseasesAllergyImmunology
2012English

Autologous Cell-Based Therapy for Treatment of Large Bone Defects: From Bench to Bedside

European Journal of Trauma and Emergency Surgery
Sports MedicineEmergency MedicineCritical CareOrthopedicsIntensive Care MedicineSurgery
2018English

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

Frontiers in Immunology
AllergyImmunology
2018English

Superficial Radiotherapy as a Treatment Alternative for Recurrent Conjunctival Squamous Cell Carcinoma: A Case Study

Journal of Medical Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy